SCHEMBL8057145

SCHEMBL8057145

CC=C(c1ccccc1)c1ccccc1NC(=O)OCCCC

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 5/20 0.67
CYP1A2 P05177 3/20 0.67
CYP2C19 P33261 3/20 0.67
ALDH1A1 P00352 7/20 0.59
L3MBTL1 Q9Y468 5/20 0.50
RAB9A P51151 5/20 0.50
HPGD P15428 3/20 0.50
LMNA P02545 3/20 0.50
KDM4E B2RXH2 2/20 0.50
MAPT P10636 1/20 0.49
TSHR P16473 5/20 0.48
TDP1 Q9NUW8 3/20 0.48
PLK1 P53350 1/20 0.47
NPC1 O15118 4/20 0.47
CYP2C9 P11712 1/20 0.47
CYP3A4 P08684 2/20 0.47
MAPK1 P28482 2/20 0.47
CASP1 P29466 1/20 0.46
NPSR1 Q6W5P4 1/20 0.45
NFKB1 P19838 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2320061 0.84 SMN1; SMN2 (0.77) SMN1; SMN2CYP1A2CYP2C19ALDH1A1L3MBTL1
SCHEMBL3848857 0.80 SMN1; SMN2 (0.63) SMN1; SMN2CYP1A2CYP2C19ALDH1A1L3MBTL1
SCHEMBL6024696 0.80 SMN1; SMN2 (0.75) SMN1; SMN2CYP1A2CYP2C19ALDH1A1L3MBTL1
SCHEMBL22822387 0.80 SMN1; SMN2 (0.70) SMN1; SMN2CYP1A2CYP2C19ALDH1A1L3MBTL1
SCHEMBL3135286 0.79 SMN1; SMN2 (0.82) SMN1; SMN2CYP1A2CYP2C19ALDH1A1L3MBTL1
SCHEMBL10916752 0.78 SMN1; SMN2 (0.76) SMN1; SMN2CYP1A2CYP2C19ALDH1A1L3MBTL1
SCHEMBL7378894 0.76 SMN1; SMN2 (0.68) SMN1; SMN2CYP1A2CYP2C19ALDH1A1L3MBTL1
SCHEMBL3867996 0.76 SMN1; SMN2 (0.68) SMN1; SMN2CYP1A2CYP2C19ALDH1A1L3MBTL1
SCHEMBL13506223 0.76 SMN1; SMN2 (0.68) SMN1; SMN2CYP1A2CYP2C19ALDH1A1L3MBTL1
SCHEMBL6389043 0.75 SMN1; SMN2 (0.64) SMN1; SMN2CYP1A2CYP2C19ALDH1A1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6057311-A TREATING EATING DISORDERS JAMES BLACK FOUNDATION LIMITED (GB) 2000-05-02 US disclosed
WO-1997032860-A1 BENZODIAZONINE DERIVATIVES BINDING TO CHOLECYSTOKININ OR GASTRIN RECEPTORS JAMES BLACK FOUNDATION LIMITED (GB) 1997-09-12 WO disclosed